Header Ads

Header ADS

Emerging and Re-emerging health issue- Nursing Wrold

                                             
                                                            

EMERGING & RE-EMERGING HEALTH ISSUE

 

 

 

 

Emerging Health Issue: Countries in the all over world continue to be hotspots for emerging and reemerging infectious diseases. Outbreaks of such diseases have a significant impact on health and economic development in the world. About maximum countries in the world have reported epidemics from emerging infectious disease over the past 10 years with the potential for global spread.

 

 

The principal risk factors contributing to the emergence and rapid spread of epidemic diseases in the Region include acute and protracted humanitarian emergencies resulting in fragile health systems, increased population mobility (travel and displacement), rapid urbanization, climate change, weak surveillance and limited laboratory diagnostic capacity, and increased human–animal interaction.

 

 

 

Emerging risks are characterized by low or non-existent scientific knowledge, high levels of uncertainty, and different levels of acceptability by the relevant authorities and exposed populations. Emerging risk must be analyzed through multiple and crossed approaches identifying the phenomenon linked to the emergence of risk but also by combining scientific, policy and social data in order to provide more enlightened decision making.

 

Emerging infectious disease:  An infectious disease that has newly appeared in a population or that has been known for some time but is rapidly increasing in incidence or geographic range.

 

There are emerging infectious diseases. Our government and other health related society works to detect, characterise and respond to emerging infectious disease threats.

 

 

Emerging infectious disease:

 

Ø  HIV infections

Ø  SARS

Ø  Lyme disease

Ø Escherichia coli O157:H7 (E. coli)

Ø Hantavirus

Ø Dengue fever

Ø  West Nile virus and

Ø  The Zika virus.

 

The risk of emerging disease: Traveling abroad can put you at risk for infectious diseases that are not widespread in the United States. Travelers who become ill in a country where treatment for these diseases may be somewhat limited are even more at risk. All people planning travel should become informed about the potential hazards of the countries they are traveling to. Learn how to reduce their risk of getting these diseases.

 

Development of Emerging Health Issue: We use our understanding of likely routes of infection transfer to develop new interventions. We aim to identify methods that are practical and affordable, and so would be suitable for wider scale-up.

For example, we have developed bamboo skirts to prevent contamination of date palm sap with bat saliva and urine, an important route for Nipah transmission to humans. We are also working on interventions to limit spread of avian influenza in live bird markets.

We are evaluating a range of strategies to prevent disease transmission. These include vaccination of people and of potential reservoir organisms (e.g. cattle for anthrax, pigs for Japanese encephalitis). We are also evaluating communication campaigns to reduce the risk of Nipah infection.

We routinely respond to infectious disease outbreaks in Bangladesh in partnership with the Institute of Epidemiology, Disease Control and Research (IEDCR), and in collaboration with the local One Health initiative.

 

RE-EMERGING HEALTH ISSUE

 

Reemerging diseases are diseases that reappear after they have been on a significant decline. Reemergence may happen because of a breakdown in public health measures for diseases that were once under control. They can also happen when new strains of known disease-causing organisms appear. Human behavior affects reemergence. For example, overuse of antibioticshas led to disease-causing organisms that are resistant to medicines. It has allowed a return of diseases that once were treatable and controllable.

Figure 1 Re-emerging Issue

 

 

There are many countries who are suffering from various type of re-emerging infectious disease. The mission of WHO Health Emergencies (WHE) Program is to build the capacity of Member States to manage health emergency risks and, when national capacities are overwhelmed, to lead and coordinate the international health response to contain outbreaks and to provide effective relief and recovery to affected populations

 

There are some re-emerging infectious disease.

Including

v malaria,

v  tuberculosis,

v  cholera,

v  pertussis,

v  influenza,

v pneumococcal disease and

v  gonorrhea.

 

 

 

 

Re-emerging health issues in the workplace:

 

ü Increase in HIV_AIDS

ü Increase in respiratory diseases, UTI

ü Increase in gastrointestinal-related diseases, Crdiovascular diseases.

ü Persistence of obesity as number one in annual physical examinations.

ü Resurgence of PTB

ü Substance abuse

 

 

 

Different between emerging and re-emerging disease:

 

Emerging

Re-emerging

1.   Disease that have not occurred in humans before or that occurred only in small number in isolated places.

 

2.   e. g. HIV infections, SARS, Lyme disease, Escherichia coli O157:H7 (E. coli), hantavirus, dengue fever, West Nile virus, and the Zika virus.

 

 

1.   Diseases that once were major health problems globally or in a particular country and then declined dramatically. But are again becoming health problems for a significant proportion of the population.

 

 

2.   eg .Malaria, tuberculosis, cholera, pertussis etc.

 

 

 credit: md. Rayhan Ali

RpNC

Ref:

 

 

  1. Haq Z, Mahjour J, Khan W. Communicable diseases in the Eastern Mediterranean Region: prevention and control 2010–2011. East Mediterr Health J (2013) 19(10):888–91.
  2. Abubakar A, Malik M, Pebody RG, Elkholy AA, Khan W, Bellos A, et al. Burden of acute respiratory disease of epidemic and pandemic potential in the WHO Eastern Mediterranean Region: a literature review. East Mediterr Health J (2016) 22(7):513–26.
  3.  Morens DM, Fauci AS. Emerging infectious diseases: threats to human health and global stability. PLoS Pathog (2013) 9(7):e1003467. doi:10.1371/ journal.ppat.1003467 .
  4. Mokdad AH, Forouzanfar MH, Daoud F, El Bcheraoui C, Moradi-Lakeh M, Khalil I, et al. Health in times of uncertainty in the eastern Mediterranean region, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet Glob Health (2016) 4(10):e704–13. doi:10.1016/S2214- 109X(16)30168-1 .
  5.  Soghaier MA, Hagar A, Abbas MA, Elmangory MM, Eltahir KM, Sall AA. Yellow fever outbreak in Darfur, Sudan in October 2012; the initial outbreak investigation report. J Infect Public Health (2013) 6(5):370–6. doi:10.1016/ j.jiph.2013.04.007 6
 

No comments

Powered by Blogger.